Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00025935 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Studies of Brain Function and Course of Illness in Pediatric Bipolar Disorder

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

The 50 most recent of 389 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fields
  2. Re-verified, no change to tracked fields
  3. Eligibility criteria expanded, about 1 word Study description shortened, about 4 words Show 1 more changeShow less
    • Study description shortened, about 4 words
  4. 28 versions Re-verified since Nov 27, 2025, no change to tracked fieldsv359-v386
  5. Study description expanded, about 6 words Eligibility criteria expanded, about 2 wordsv358 Show 1 more changeShow less
    • Eligibility criteria expanded, about 2 words

    See this version in full on ClinicalTrials.gov ↗

Show 18 earlier versionsHide 18 earlier versions
  1. 4 versions Re-verified since Jul 31, 2025, no change to tracked fieldsv354-v357
  2. Eligibility criteria revised Study description shortened, about 2 wordsv353 Show 1 more changeShow less
    • Study description shortened, about 2 words

    See this version in full on ClinicalTrials.gov ↗

  3. 8 versions Re-verified since Apr 30, 2025, no change to tracked fieldsv345-v352
  4. Study Status, Study Description, Eligibilityv344
  5. 4 versions Re-verified since Dec 20, 2024, no change to tracked fieldsv340-v343
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study seeks to learn more about the symptoms of severe mood dysregulation in children and adolescents ages 7-17. Children and adolescents with severe mood dysregulation (SMD) display chronic anger, sadness, or irritability, as well as hyperarousal (such as insomnia, distractibility, hyperactivity) and extreme responses to frustration (such as frequent, severe temper tantrums). Researchers will describe the moods and behaviors of children with these symptoms and use specialized testing and brain imaging to learn about the brain changes associated with this disorder.
Trial Details
NCT Number NCT00025935
Lead Sponsor National Institute of Mental Health (NIMH)
Conditions Mood Disorder
Enrollment 2,350 participants
Start Date
Updated on ClinicalTrials.gov